Vytrus Biotech S.A. (VYT) — Free Cash Flow Generation Index
Vytrus Biotech S.A. (VYT) has a Free Cash Flow Generation Index of 3.19x as of December 2022. Free cash flow of €719.71K represents 3% of operating cash flow (€225.55K). Explore how much does Vytrus Biotech S.A. reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.
FCF Generation Index
Free Cash Flow
Operating Cash Flow
Capital Expenditures
Vytrus Biotech S.A. Free Cash Flow Generation Index (2021–2025)
Historical FCF Generation Index trend for Vytrus Biotech S.A. across 5 annual periods. For the full cash flow conversion analysis, see Vytrus Biotech S.A. cash flow conversion.
Annual Free Cash Flow Generation for Vytrus Biotech S.A. (2021–2025)
Year-by-year Free Cash Flow Generation Index for Vytrus Biotech S.A.. Check VYT cash reinvestment to operating cash ratio to assess the company's total reinvestment commitment from operating cash flow.
| Year | FCG Index | Free Cash Flow (EUR) | Operating CF | Capital Expenditures | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.31x | €1.22 Million | €3.90 Million | €2.68 Million | ▼ -9.8% |
| 2024 | 0.35x | €640.24K | €1.84 Million | €1.20 Million | ▲ +219.9% |
| 2023 | -0.29x | €-261.83K | €904.39K | €1.17 Million | ▲ +75.7% |
| 2022 | -1.19x | €-268.62K | €225.55K | €494.16K | ▼ -402.9% |
| 2021 | 0.39x | €176.11K | €447.92K | €271.82K | — |